Advertisement
UK markets close in 7 hours 28 minutes
  • FTSE 100

    8,123.20
    +44.34 (+0.55%)
     
  • FTSE 250

    19,749.70
    +147.72 (+0.75%)
     
  • AIM

    755.84
    +2.72 (+0.36%)
     
  • GBP/EUR

    1.1651
    -0.0006 (-0.05%)
     
  • GBP/USD

    1.2508
    -0.0003 (-0.03%)
     
  • Bitcoin GBP

    51,413.32
    +236.95 (+0.46%)
     
  • CMC Crypto 200

    1,388.40
    -8.13 (-0.58%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    83.97
    +0.40 (+0.48%)
     
  • GOLD FUTURES

    2,357.70
    +15.20 (+0.65%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,656.30
    +371.76 (+2.15%)
     
  • DAX

    18,027.45
    +110.17 (+0.61%)
     
  • CAC 40

    8,041.24
    +24.59 (+0.31%)
     

3 No-Brainer Stocks to Buy for Under $100 Right Now

3 No-Brainer Stocks to Buy for Under $100 Right Now

Here's why they chose CRISPR Therapeutics (NASDAQ: CRSP), Novocure (NASDAQ: NVCR), and Pfizer (NYSE: PFE). David Jagielski (CRISPR Therapeutics): Shares of CRISPR Therapeutics are trading below $70, but it may not be long before they take off. The company has a promising gene-editing therapy in exa-cel for rare blood disorders beta-thalassemia and sickle cell disease that it has been working on with Vertex Pharmaceuticals.